Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin-1 in Metastatic Renal Cell Carcinoma
NCT00003968Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1999
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Jun 1999; status: completed.
02
Drugs
bryostatin-1
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003968.